SEC Form 5 · accession 0001250853-15-000029
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sanford Hillsberg
Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2014 | G | 10,000 | $0.00 | D | 85,447 | I | Family Trust |
| Common Stock | holding | — | — | — | 17,974 | D |
Table II — derivative securities
No Table II lines on this filing.